Back to marketplace
EAST INDIA PHARMA· ISIN INE254X01017· Kolkata, West Bengal, India· Est. 1936 Verified
East India Pharmaceutical Works Limited logo

East India Pharmaceutical Works Limited

Pharmaceuticals
₹79+0.00%

vs. prev. close ₹79

Market cap

₹53 Cr

IPO stage

No DRHP filed

CIN

U24231WB1936PLC008598

Price History

About East India Pharmaceutical Works Limited

Get the latest East India Pharmaceutical unlisted share price. Buy or sell East India Pharmaceutical shares with ease, stay updated with UnlistedZone.

A) Introduction East India Pharmaceutical Works Limited (EIPWL) is one of India's oldest pharmaceutical companies, established in 1936 and headquartered in Kolkata, West Bengal. With over eight decades of experience, EIPWL has built a strong presence in the Indian pharmaceutical industry, focusing on manufacturing and marketing a diverse range of healthcare products. B) Business Model & Operations EIPWL operates in the pharmaceutical sector, focusing on the development, manufacturing, and marketing of a wide range of healthcare products. The company's operations are divided between in-house manufacturing and contract manufacturing under a loan-licensing model. EIPWL also produces and markets a few Ayurvedic medicines C) Product Portfolio EIPWL offers a diverse range of products across various therapeutic segments, including: Analgesics & Antipyretics: Pyrigesic 650, Pyrigesic 1000 Haematinics: Tonoferon Digestive Enzymes: Vitazyme Eye Care Products: Locula (10%, 20%, 30%) Antibacterials & Anti-infectives: Tisol-200 Ayurvedic Products: URJ Personal Care: Sandalite Body Oil (Sandal & Rose variants), Sandalite Honey Facewash D) Market Reach EIPWL has a significant presence across India, with: Employees: Over 1,000 Sales Personnel: Approximately 800 Sales Offices: Multiple across the country Marketing Intermediaries: Extensive network supporting nationwide distribution E) Financial Performance For the fiscal year ending March 31, 2024, EIPWL reported: Operating Income: ₹249 crore (up from ₹233.7 crore in FY2023) Net Profit: ₹30.78 crore (up from ₹24.31 crore in FY2023) Return on Equity (ROE): 6.89% Debt-Equity Ratio: 0.88 Net Profit Margin: 1.55% F) Manufacturing Facilities EIPWL's manufacturing operations are primarily based in: Sarsuna, Kolkata: Main facility equipped with modern, AI-driven machinery and houses the R&D team. Durgapur, West Bengal: Synthetic drugs plant situated in an eco-friendly environment. G) Recent Developments Product Launches: Introdu

Company Details

Industry

Pharmaceuticals

Founded

1936

Headquarters

Kolkata, West Bengal, India

Min Lot Size

1

Face Value

₹10.00

Shares Outstanding

66,74,858

Regulatory Information

Corporate Identity Number (CIN)

U24231WB1936PLC008598

PAN Number

AAACE5779P

ISIN

INE254X01017

Key Valuation Ratios

As of FY2025 Annual · updated 07 Nov 2026Derived

Valuation

Market Cap

₹52.73 Cr

P/E Ratio

23.86×

P/S Ratio

0.19×

P/B Ratio

0.91×

EV / EBITDA

7.69×

Returns & Per Share

ROE

3.82%

EPS

₹3.31

Book Value / Share

₹86.62

Solvency

Debt / Equity

0.92×

Interest Coverage

1.68×

Company Fundamentals

As of FY2025 Annual · updated 07 Nov 2026

Gross Profit

₹196.44 Cr

EBITDA

₹12.70 Cr

Revenue Growth

8.76%

Profit Margin

0.81%

Performance Trends

3 annual periods · derived from filed statements

As of FY2025 Annual · updated 07 Nov 2026

Revenue

₹ Cr

Net Profit

₹ Cr · losses in red

Earnings Per Share

₹ per share

Return on Equity

ROE %

Return on Capital Employed

ROCE %

Debt-to-Equity

0.92×

EBITDA Margin

4.67%

Interest Coverage

1.68×

Financial Statements

As of FY2025 Annual · updated 07 Nov 2026
Disclosed reportedDerived calculated
Line itemFY2023FY2024FY2025
Total Income
Revenue from operationsDisclosed233.69₹ Crore249.81₹ Crore271.69₹ Crore
Other incomeDisclosed8₹ Lakh13₹ Lakh15₹ Lakh
Total IncomeDerived233.77₹ Crore249.94₹ Crore271.84₹ Crore
Expenses
Cost of goods soldDisclosed74.14₹ Crore72.45₹ Crore75.25₹ Crore
Purchases of stock-in-tradeDisclosed4.54₹ Crore6.98₹ Crore8.57₹ Crore
Changes in inventoriesDisclosed4.3₹ Crore-40₹ Lakh7.92₹ Crore
Employee benefits expenseDisclosed77.18₹ Crore89.81₹ Crore94.41₹ Crore
Finance costsDisclosed4.69₹ Crore5.47₹ Crore6.17₹ Crore
Depreciation and amortization expenseDisclosed2.44₹ Crore2.58₹ Crore2.34₹ Crore
Manufacturing expensesDisclosed0₹ Crore0₹ Crore0₹ Crore
Operating expensesDisclosed0₹ Crore0₹ Crore0₹ Crore
Other expensesDisclosed64.06₹ Crore69.96₹ Crore72.99₹ Crore
Total ExpensesDerived231.35₹ Crore246.85₹ Crore267.65₹ Crore
Profit
Exceptional itemsDisclosed0₹ Crore1.46₹ Crore0₹ Crore
Profit before taxDerived2.42₹ Crore4.55₹ Crore4.19₹ Crore
Current tax expenseDisclosed1.1₹ Crore1.25₹ Crore1.8₹ Crore
Deferred tax expenseDisclosed-28₹ Lakh-69₹ Lakh-62₹ Lakh
Tax expenseDisclosed74₹ Lakh67₹ Lakh1.98₹ Crore
Profit After TaxDerived1.68₹ Crore3.88₹ Crore2.21₹ Crore
Other comprehensive incomeDisclosed0₹ Crore0₹ Crore0₹ Crore
Total Comprehensive IncomeDerived1.68₹ Crore3.88₹ Crore2.21₹ Crore

Documents Library

Access all financial reports and filings

Annual Report

annual report 2023

2023
2.0 MB

annual report 2024

2024
3.5 MB

annual report 2025

2025
0.4 MB

Shareholding Pattern

Others

74.13%

Others

74.13%

Promoters

25.87%

Promoters

25.87%

D

D. Duttagupta

Managing Director

30+

M

Mrs. S. Mukherjee

Director

25+

S

S. Ray

CFO

30+

Express buy interest

No commitment — the desk will reach out

Current Price

₹79
+0.00%
Min lot: 1
Price/share₹79
Quantity100
Estimated Total₹7,900

Secure & Verified Transaction

Unlisted shares are illiquid and carry higher market risks. Please read the Risk Disclosure before investing.

Talk to a Specialist

Get expert guidance on this investment

About East India Pharmaceutical Works Limited unlisted shares

Indicative · updated daily

East India Pharmaceutical Works Limited unlisted share price today

East India Pharmaceutical Works Limited unlisted share price today is ₹79 as of 12 November 2026.

East India Pharmaceutical Works Limited — frequently asked questions

What is the grey market price for East India Pharmaceutical Works Limited?

No IPO is currently announced for East India Pharmaceutical Works Limited, so no grey market exists; the price above reflects Priveq's own desk valuation.

Has East India Pharmaceutical Works Limited filed for an IPO, and when might it list?

East India Pharmaceutical Works Limited has not filed a draft red herring prospectus, so no IPO is currently announced and no listing date has been set.

How does East India Pharmaceutical Works Limited compare to its listed peers?

There is no closely comparable listed company for East India Pharmaceutical Works Limited in India today.

Is East India Pharmaceutical Works Limited on the SME or Mainboard IPO track?

East India Pharmaceutical Works Limited has not filed a draft red herring prospectus, so no IPO track is set yet.

What is East India Pharmaceutical Works Limited's CIN and registered office?

East India Pharmaceutical Works Limited's Corporate Identity Number is U24231WB1936PLC008598, registered at Kolkata, West Bengal, India.

What is East India Pharmaceutical Works Limited's market capitalisation?

East India Pharmaceutical Works Limited's market capitalisation is approximately ₹53 crore, based on its current unlisted share price.

All Pharmaceuticals →

Buying, selling and holding unlisted shares

Applies to every company on Priveq
How do I buy East India Pharmaceutical Works Limited unlisted shares?

Priveq Investech Private Limited is the named counterparty on every transaction. To buy East India Pharmaceutical Works Limited unlisted shares: complete KYC once (PAN, Aadhaar, bank details, and demat account information — SEBI-compliant, typically approved within 24 hours), then submit your order through your Priveq dashboard specifying quantity. Our team confirms price and payment details with you directly. Once payment is confirmed, East India Pharmaceutical Works Limited shares are transferred off-market straight to your demat account, with no pooling and no middlemen.

How do I sell East India Pharmaceutical Works Limited unlisted shares?

Submit an Express Sell Interest for East India Pharmaceutical Works Limited through your Priveq dashboard, specifying quantity, the same way a buy order is placed. Priveq quotes you a bid price, which may differ from the live Buy price shown to buyers, since unlisted-share pricing works on a bid-ask basis rather than a single quote. Once you accept, you'll need to provide your Client Master List (CML), a cancelled cheque or bank details, and PAN. If you hold shares with CDSL, transfer can also be completed digitally via CDSL Easiest. You transfer East India Pharmaceutical Works Limited shares to Priveq first, and payment follows once the transfer is confirmed received, typically the same day, T+1, or occasionally T+2, communicated to you directly. For sizeable transactions worth crores of rupees, an escrow arrangement can be used instead, at the sole consent of both parties.

What is the minimum investment for East India Pharmaceutical Works Limited unlisted shares?

Minimum investment varies by company and is shown as the Min Investment figure on this page. East India Pharmaceutical Works Limited's minimum is ₹79.

Is there a maximum investment limit?

There's no fixed maximum investment limit for East India Pharmaceutical Works Limited unlisted shares. For sizeable transactions worth crores of rupees, an escrow arrangement can be used at the sole consent of both parties, the same mechanism available on the sell side.

Is buying East India Pharmaceutical Works Limited unlisted shares legal in India?

Yes. Buying and selling unlisted shares in India is legal and is subject to relevant SEBI regulations, including the mandatory lock-in period after listing, stamp duty, and depository participant charges on each transaction. Priveq's own KYC process is built to be SEBI-compliant.

What is the lock-in period for East India Pharmaceutical Works Limited unlisted shares?

East India Pharmaceutical Works Limited has not filed a DRHP yet, so no listing date or lock-in period applies at this stage. Once an IPO is filed, this answer updates to reflect the applicable SME or Mainboard lock-in.

What happens if East India Pharmaceutical Works Limited's IPO is delayed or withdrawn?

If an IPO is delayed, shares remain unlisted and continue to trade on the desk at Priveq's indicative price, with no lock-in in effect until an actual listing happens. If a company formally withdraws its DRHP, the same applies: shares stay unlisted, with no lock-in period until and unless a fresh IPO process begins.

How are capital gains on East India Pharmaceutical Works Limited unlisted shares taxed?

If you sell unlisted shares, including East India Pharmaceutical Works Limited, within 24 months of purchase, the gain is taxed as short-term capital gain at your applicable income tax slab rate. Beyond 24 months, it is taxed as long-term capital gain at 12.5 percent, without indexation benefit, under the rules effective from 23 July 2024. If East India Pharmaceutical Works Limited lists and you sell after listing, the applicable tax treatment shifts to listed-security rates, with the holding period still measured from your original unlisted purchase date. This is general information, not tax advice; investors should confirm their specific position with a tax advisor.

Can NRIs invest in East India Pharmaceutical Works Limited unlisted shares?

Yes, on a non-repatriable basis. NRIs can invest using funds from an NRO account; sale proceeds stay within India unless repatriated separately under RBI's own limits. Priveq does not currently support repatriable investment (NRE/FCNR-funded), which would require the investee company to file additional RBI paperwork as foreign direct investment.

Does Priveq charge a platform fee on top of the share price?

No. The price quoted to you is all-in; there is no separate platform fee or brokerage added on top.

How does Priveq determine the desk price for East India Pharmaceutical Works Limited?

Priveq's desk price reflects several inputs together, not a single formula: the seller's ask price at the time, current demand and supply on the platform for East India Pharmaceutical Works Limited specifically, broader sentiment in the unlisted and pre-IPO market, how East India Pharmaceutical Works Limited's sector and listed peers are trading, the company's own recent financial performance and IPO-stage developments, and recent transaction history where deals have actually closed.

Because unlisted shares trade over the counter rather than on an exchange, this price is indicative, not a continuously live quoted market price, and the actual deal price is confirmed with you directly before a transaction closes.

Is Priveq SEBI-registered? Does it give investment advice?

Priveq is not a SEBI-registered stock exchange and not a SEBI-registered investment adviser. Priveq Investech Private Limited operates Priveq.in as a research and information platform for unlisted and pre-IPO shares, and is the named counterparty on transactions executed through the platform. Nothing on this page is investment advice; it's information to help you evaluate a company and decide for yourself.

Am I eligible to invest through Priveq if I'm not an HNI?

Yes. Priveq isn't a stock exchange with membership restrictions, and investing isn't limited to HNIs. Depending on the company, entry points can start as low as ₹20,000, though the minimum for any specific company is shown as the Min Investment figure on its page.

What documents do I receive after buying unlisted shares?

You receive an email acknowledging and confirming your order, along with a deal note or invoice recording the transaction details.

What happens to my shares or money if a deal falls through?

Because Priveq is the direct counterparty on every transaction rather than just connecting a buyer and seller, this risk sits with Priveq, not with you. If a deal falls through after you've committed funds or shares, they remain safe, and Priveq guarantees a refund.

Chat with us